Cargando…

Effect of Landiolol Hydrochloride on Hemodynamics in a Histamine-Induced Shock Model

BACKGROUND AND OBJECTIVE: Anaphylactic shock is a serious adverse drug reaction that can occur in response to contrast media used during coronary computed tomography angiography. The imaging quality of coronary computed tomography angiography is improved by β-blockers, which decrease heart rate. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirano, Masaharu, Okamura, Tatsuaki, Nagano, Tetsuji, Nonaka, Shigeyuki, Shiroya, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363724/ https://www.ncbi.nlm.nih.gov/pubmed/34128200 http://dx.doi.org/10.1007/s40268-021-00354-3

Ejemplares similares

Perioperative Administration of an Intravenous Beta-Blocker Landiolol Hydrochloride in Patients with Lung Cancer: A Japanese Retrospective Exploratory Clinical Study
por: Sakamoto, Atsuhiro, et al.
Publicado: (2019)

Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies
por: Ashida, Atsuko, et al.
Publicado: (2021)

Study of hemodynamics in patients treated with landiolol in the ICU
por: Imabayashi, T, et al.
Publicado: (2009)

Dose-Finding Study of Landiolol Hydrochloride: A Short-Acting β(1)-Blocker for Controlling Heart Rate During Coronary Computed-Tomography Angiography in Japan
por: Hirano, Masaharu, et al.
Publicado: (2013)

Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
por: Kinugawa, Koichiro, et al.
Publicado: (2014)

Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension
por: Schroeder, Lukas, et al.
Publicado: (2022)

Erratum to: Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
por: Kinugawa, Koichiro, et al.
Publicado: (2014)

Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial disease
por: Kunisawa, Takayuki, et al.
Publicado: (2015)

Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial
por: Aoki, Yoshitaka, et al.
Publicado: (2020)

Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature
por: Matsuishi, Yujiro, et al.
Publicado: (2020)

A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β(1)-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease
por: Jinzaki, Masahiro, et al.
Publicado: (2013)

Landiolol reduces hemodynamic responses to bronchoscopy-assisted suctioning in intubated ICU patients
por: Tochikubo, Junpei, et al.
Publicado: (2014)

Effects of Olopatadine Hydrochloride, a Histamine H(1) Receptor Antagonist, on Histamine-Induced Skin Responses
por: Hashimoto, Takashi, et al.
Publicado: (2010)

Hemodynamic and Rhythmologic Effects of Push-Dose Landiolol in Critical Care—A Retrospective Cross-Sectional Study
por: Schnaubelt, Sebastian, et al.
Publicado: (2023)

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Short-Acting β(1)-Adrenergic Receptor Blocker Landiolol Hydrochloride for Coronary Computed Tomography Angiography in Japanese Patients with Suspected Ischemic Cardiac Disease
por: Hirano, Masaharu, et al.
Publicado: (2013)

Safety of Landiolol Hydrochloride as a Premedication for Producing an Appropriate Heart Rate for Multidetector-Row Computed Tomography Coronary Angiography
por: Koyoshi, Rie, et al.
Publicado: (2018)

A case of ultrashort‐acting beta‐blocker landiolol hydrochloride for takotsubo syndrome with left ventricular outflow tract obstruction
por: Takama, Takuro, et al.
Publicado: (2018)

Beta-Blocker Landiolol Hydrochloride in Preventing Atrial Fibrillation Following Cardiothoracic Surgery: A Systematic Review and Meta-Analysis
por: Hao, Jianqi, et al.
Publicado: (2021)

Safety and effective use of landiolol in the ICU
por: Hifumi, Toru, et al.
Publicado: (2014)

A Multicenter, Open-Label Study of an Intravenous Short-Acting β(1)-Adrenergic Receptor Antagonist Landiolol Hydrochloride for Coronary Computed Tomography Angiography by 16-Slice Multi-Detector Computed Tomography in Japanese Patients with Suspected Ischemic Cardiac Disease
por: Hirano, Masaharu, et al.
Publicado: (2014)

Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study
por: Matsuda, Naoyuki, et al.
Publicado: (2020)

CONDITION OF THE CAPILLARIES IN HISTAMINE SHOCK
por: Rich, Arnold Rice
Publicado: (1921)

Landiolol for managing atrial fibrillation in intensive care
por: Rehberg, Sebastian, et al.
Publicado: (2018)

Landiolol for managing post-operative atrial fibrillation
por: Balik, Martin, et al.
Publicado: (2018)

Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial
por: Lall, Ranjit, et al.
Publicado: (2021)

Landiolol for managing atrial fibrillation in post-cardiac surgery
por: Fellahi, Jean-Luc, et al.
Publicado: (2018)

Anaphylactic shock in a patient with severe aortic stenosis treated with adrenaline and landiolol for circulatory management: A case report
por: Yokoyama, Akihiro, et al.
Publicado: (2021)

The role of landiolol in the management of atrial tachyarrhythmias in patients with acute heart failure and cardiogenic shock: case reports and review of literature
por: Bezati, Sofia, et al.
Publicado: (2022)

The Effectiveness and Safety of Landiolol Hydrochloride, an Ultra-Short-Acting β(1)-Blocker, in Postoperative Patients with Supraventricular Tachyarrhythmias: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
por: Taenaka, Nobuyuki, et al.
Publicado: (2013)

Effect of landiolol on sex-related transcriptomic changes in the myocardium during sepsis
por: Tran, Thi Thom, et al.
Publicado: (2019)

Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports
por: Gangl, Clemens, et al.
Publicado: (2022)

Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial
por: Unger, Martin, et al.
Publicado: (2018)

Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS
por: Apolloni, Savina, et al.
Publicado: (2019)

Effects of dexmedetomidine hydrochloride on hemodynamics, postoperative analgesia and cognition in cesarean section
por: Kong, Dehua, et al.
Publicado: (2018)

Brain protective effect and hemodynamics of dexmedetomidine hydrochloride in patients with intracranial aneurysm
por: Zheng, Deli, et al.
Publicado: (2020)

Landiolol for rate control management of atrial fibrillation in patients with cardiac dysfunction
por: von Haehling, Stephan, et al.
Publicado: (2018)

Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults
por: Krumpl, Günther, et al.
Publicado: (2020)

Mid-Term Prognosis After Landiolol Treatment in Atrial Fibrillation/Atrial Flutter Patients With Chronic Heart Failure　― A Prospective Observational Survey (AF-CHF Landiolol Survey) ―
por: Yamashita, Takeshi, et al.
Publicado: (2020)

RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock
por: Mikelis, Constantinos M., et al.
Publicado: (2015)

ET-26 hydrochloride (ET-26 HCl) has similar hemodynamic stability to that of etomidate in normal and uncontrolled hemorrhagic shock (UHS) rats
por: Wang, Bin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j2aa4obn3t53c6tjh803h6n5u9